EP300 and plasma cell myeloma: To investigate the presence of the endogenous SEI1/CBP/p300/PAF1 complex in myeloma cells, we performed immunoprecipitation assays using anti‐SEI1, PAF1, CDC73, or p300 antibodies on myeloma cell lysates.